Dalan Animal Health Closes $3.55 Million Financing Round For Launch Of The World’s First Honeybee Vaccine

Sep 27, 2022•about 3 years ago

Amount Raised

$3.55 Million

Round Type

seed

AthensBiotechnologyFarming

Description

Dalan Animal Health, Inc., a biotech company pioneering insect health and immunology, today announced the close of a $3.55 million seed financing round led by At One Ventures and Veterinary Angel Network for Entrepreneurs (VANE). This is the second seed round of funding and the first including institutional investors, bringing the total raise to $5.5 million.

Company Information

Company

Dalan Animal Health

Location

210 Spring Street

Athens, Georgia, United States

About

Dalan Animal Health is dedicated to bringing the world transformative animal health solutions to support a more sustainable future. As the pioneer in invertebrate vaccines, Dalan developed the world's first USDA-approved vaccine for honeybees and is advancing the first vaccine for shrimp using its proprietary Innate Immunity Platform technology. The company's platform leverages conserved immune pathways to provide broad-spectrum disease protection across multiple animal species. Dalan's biotech innovation has been recognized through numerous international awards including TIME's Best Inventions, Fast Company's Next Big Things in Tech, and SVG THRIVE Global Impact Challenge winner (2025).

Related People

4 contacts

Dalan Animal Health Closes $3.55 Million Financing Round For Launch Of The World’s First Honeybee Vaccine

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Company Information